Please assess the completion status of the following clinical trial:

Trial Title: Registry Study of Neoadjuvant Chemoradiation & Transplant for Cholangiocarcinoma Patients

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_ONLY
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~1. Diagnosis of cholangiocarcinoma that has been established preoperatively by at least one of the following criteria:~   1. A positive brush cytology or biopsy result obtained at the time of cholangiography;~  2. Fluorescence in situ hybridization demonstrating aneuploidy;~  3. A serum CA 19-9 value greater than 100 U/mL in the presence of a radiographically characteristic malignant stricture in the absence of cholangitis.~  4. Listed for OLT for hilar cholangiocarcinoma~2. Tumor/stricture is above the cystic duct and is unresectable.~3. A suitable candidate for orthotopic liver transplantation as judged by the liver transplant team. All 3 treatment modalities are not needed to confirm eligibility for this registry trial.~4. \>/= 18 years of age.~5. Willing and able to provide written informed consent.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: None): Patients with unresectable cholangiocarcinoma.

Based on this trial design, predict the completion outcome and termination type (if applicable).